Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Key Research Features Dual-mechanism research blend angiogenic + cytoskeletal pathways BPC-157: VEGF/VEGFR2-Akt-eNOS axis and NO system modulation TB-500: actin sequestration and G-actin/F-actin polymerization balance Precision co-lyophilized 1:1 ratio minimizes preparation variability 20mg total content suited for high-throughput and extended protocols 99% HPLC-verified purity per component Lyophilized powder format Suitable for in vitro and preclinical research Batch-tested for consistency Research-grade manufacturing standards Professionally labeled and documented Storage Recommendations To maintain product stability and research integrity, BPC-157 / TB-500 should be: Stored at 20C in a tightly sealed container Reconstituted with sterile bacteriostatic water, added slowly along the vial wall with gentle swirling avoid vigorous shaking Protected from light and moisture Kept sealed until use Handled according to standard laboratory procedures Not subjected to repeated freeze-thaw cycles Toxicology and Regulatory Information BPC-157 evaluated in preclinical toxicology research models BPC-157 listed by the U.S
Even though it wouldnt be harmful, but the potency will be diminished
Skip to content Welcome Offer Enjoy a limited-time welcome discount on your first visit
By targeting specific areas of concern, it offers a customizable approach to facial aesthetics, helping individuals achieve smoother and more toned skin textures
It is essential to be clear: the human safety data for injectable, oral, or high-dose systemic GHK-Cu is essentially absent
This dose is often enough to treat most deficiencies
